Related references
Note: Only part of the references are listed.Akt Inhibition Enhances Expansion of Potent Tumor-Specific Lymphocytes with Memory Cell Characteristics
Joseph G. Crompton et al.
CANCER RESEARCH (2015)
Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia
Regina Jitschin et al.
BLOOD (2014)
Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions
Pravin Kesarwani et al.
CANCER RESEARCH (2014)
Autophagy is essential for effector CD8+ T cell survival and memory formation
Xiaojin Xu et al.
NATURE IMMUNOLOGY (2014)
mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity
Shih-Chin Cheng et al.
SCIENCE (2014)
Integrating canonical and metabolic signalling programmes in the regulation of T cell responses
Kristen N. Pollizzi et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Immunological characterization of multipotent mesenchymal stromal cells-The International Society for Cellular Therapy (ISCT) working proposal
Mauro Krampera et al.
CYTOTHERAPY (2013)
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
Madhusudhanan Sukumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Alterations in the Cellular Immune Compartment of Patients Treated with Third-Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation
Regina Jitschin et al.
STEM CELLS (2013)
Novel treatment concepts for graft-versus-host disease
Dominik Wolf et al.
BLOOD (2012)
Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory Development
Gerritje J. W. van der Windt et al.
IMMUNITY (2012)
PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells
David K. Finlay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR A novel IDO effector pathway targeted by D-1-methyl-tryptophan
Richard Metz et al.
ONCOIMMUNOLOGY (2012)
Multipotent mesenchymal stromal cells and the innate immune system
Katarina Le Blanc et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells
Dimitrios Mougiakakos et al.
BLOOD (2011)
Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
Ho-Jin Shin et al.
BLOOD (2011)
Regulatory T Cells Selectively Control CD8+ T Cell Effector Pool Size via IL-2 Restriction
Wolfgang Kastenmuller et al.
JOURNAL OF IMMUNOLOGY (2011)
Characterization of the Metabolic Phenotype of Rapamycin-Treated CD8+ T Cells with Augmented Ability to Generate Long-Lasting Memory Cells
Shan He et al.
PLOS ONE (2011)
Epigenomics of T cell activation, differentiation, and memory
Suresh Cuddapah et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
mTOR signalling and metabolic regulation of T cell differentiation
Christian Peter et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Direct control of mitochondrial function by mTOR
Arvind Ramanathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning
Philippe Armand et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
R Meisel et al.
BLOOD (2004)
Share Paper
